McCollaum - Genesis Regenerative

I would like to learn more about Genesis® RPA and the physician practice outline above.

First Name

Last Name *

Date Of Birth

Phone

Street

City

State

Zip Code

Country

Cash Or Finance

Any Chronic Illness or Pain

Any Chronic Illness or Pain Description

</p>
</div></div></div> 		</div></div><footer class="footer-page-content footer_color" id="footer-page"><style type="text/css" data-created_by="avia_inline_auto" id="style-css-av-lwqyp6tk-2ef28180086a791fdb640e0528384ad4">
.avia-section.av-lwqyp6tk-2ef28180086a791fdb640e0528384ad4{
background-color:#dddce2;
background-image:unset;
}
</style>
<div id='av_section_2'  class='avia-section av-lwqyp6tk-2ef28180086a791fdb640e0528384ad4 main_color avia-section-small avia-no-border-styling  avia-builder-el-0  avia-builder-el-no-sibling  avia-bg-style-scroll av-minimum-height av-minimum-height-custom av-height-custom  container_wrap fullsize'   data-av_minimum_height_px='50'><div class='container av-section-cont-open' style='height:50px'><main  role="main" itemprop="mainContentOfPage"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-2931'><div class='entry-content-wrapper clearfix'>

</div></div></main> 		</div></div></footer>

</div>

</div>
<a href='#top' title='Scroll to top' id='scroll-top-link' class='avia-svg-icon avia-font-svg_entypo-fontello' data-av_svg_icon='up-open' data-av_iconset='svg_entypo-fontello' tabindex='-1' aria-hidden='true'>
	<svg version="1.1" xmlns="http://www.w3.org/2000/svg" width="19" height="32" viewBox="0 0 19 32" preserveAspectRatio="xMidYMid meet" aria-labelledby='av-svg-title-1' aria-describedby='av-svg-desc-1' role="graphics-symbol" aria-hidden="true">
<title id='av-svg-title-1'>Scroll to top</title>
<desc id='av-svg-desc-1'>Scroll to top</desc>
<path d="M18.048 18.24q0.512 0.512 0.512 1.312t-0.512 1.312q-1.216 1.216-2.496 0l-6.272-6.016-6.272 6.016q-1.28 1.216-2.496 0-0.512-0.512-0.512-1.312t0.512-1.312l7.488-7.168q0.512-0.512 1.28-0.512t1.28 0.512z"></path>
</svg>	<span class="avia_hidden_link_text">Scroll to top</span>
</a>

<div class="um-modal-body photo">
		<div class="um-modal-photo"></div>
	</div>
</div>
<script type="speculationrules">
{"prefetch":[{"source":"document","where":{"and":[{"href_matches":"\/*"},{"not":{"href_matches":["\/wp-*.php","\/wp-admin\/*","\/wp-content\/uploads\/*","\/wp-content\/*","\/wp-content\/plugins\/*","\/wp-content\/themes\/enfold-child\/*","\/wp-content\/themes\/enfold\/*","\/*\\?(.+)"]}},{"not":{"selector_matches":"a[rel~=\"nofollow\"]"}},{"not":{"selector_matches":".no-prefetch, .no-prefetch a"}}]},"eagerness":"conservative"}]}
</script>
    <script type="text/javascript">
        var recaptchaIds = [];

function cf7srResetRecaptcha() {
            for (var i = 0; i < recaptchaIds.length; i++) {
                grecaptcha.reset(recaptchaIds[i]);
            }
        }

<div class="pum-content popmake-content" tabindex="0">
			<h3 style="text-align: center; color:black;">Request Our Educational Guide and Patient Testimonials</h3>

<div class="wpcf7 no-js" id="wpcf7-f4472-o1" lang="en-US" dir="ltr" data-wpcf7-id="4472">
<div class="screen-reader-response"><p role="status" aria-live="polite" aria-atomic="true"></p> <ul></ul></div>
<form action="/?alb_custom_layout=mccollaum#wpcf7-f4472-o1" method="post" class="wpcf7-form init" aria-label="Contact form" novalidate="novalidate" data-status="init">
<fieldset class="hidden-fields-container"><input type="hidden" name="_wpcf7" value="4472" /><input type="hidden" name="_wpcf7_version" value="6.1.4" /><input type="hidden" name="_wpcf7_locale" value="en_US" /><input type="hidden" name="_wpcf7_unit_tag" value="wpcf7-f4472-o1" /><input type="hidden" name="_wpcf7_container_post" value="0" /><input type="hidden" name="_wpcf7_posted_data_hash" value="" /><input type="hidden" name="_wpcf7_recaptcha_response" value="" />
</fieldset>
<p><label> First Name* </label><br />
<span class="wpcf7-form-control-wrap" data-name="FirstName"><input size="40" maxlength="400" class="wpcf7-form-control wpcf7-text wpcf7-validates-as-required" aria-required="true" aria-invalid="false" value="" type="text" name="FirstName" /></span>
</p>
<p><label> Last Name* </label><br />
<span class="wpcf7-form-control-wrap" data-name="LastName"><input size="40" maxlength="400" class="wpcf7-form-control wpcf7-text wpcf7-validates-as-required" aria-required="true" aria-invalid="false" value="" type="text" name="LastName" /></span>
</p>
<p><label> Email* </label><br />
<span class="wpcf7-form-control-wrap" data-name="Email"><input size="40" maxlength="400" class="wpcf7-form-control wpcf7-email wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-email" aria-required="true" aria-invalid="false" value="" type="email" name="Email" /></span>
</p>
<p><label> Phone* </label><br />
<span class="wpcf7-form-control-wrap" data-name="Phone"><input size="40" maxlength="400" class="wpcf7-form-control wpcf7-tel wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-tel" aria-required="true" aria-invalid="false" value="" type="tel" name="Phone" /></span>
</p>
<p><div id="cf7sr-69411bfa6196b" class="cf7sr-g-recaptcha" data-theme="light" data-type="image" data-size="normal" data-sitekey="6Ld2JuQrAAAAAMwPNcJUeKSy0SxdczgIR_0_-pld"></div><span class="wpcf7-form-control-wrap cf7sr-recaptcha" data-name="cf7sr-recaptcha"><input type="hidden" name="cf7sr-recaptcha" value="" class="wpcf7-form-control"></span>
</p>
<p><input class="wpcf7-form-control wpcf7-submit has-spinner" type="submit" value="Submit" />
</p><input type='hidden' class='wpcf7-pum' value='{"closepopup":false,"closedelay":0,"openpopup":false,"openpopup_id":0}' /><div class="wpcf7-response-output" aria-hidden="true"></div>
</form>
</div>

</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-1945" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_1945"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":1945,"slug":"traumatic-brain-injury-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"extra_selectors":".neurological-traumatic-brain-injury-protocol"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_1945" class="pum-title popmake-title">
				Thoracic Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Thoracic</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Traumatic Brain Injury Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-1861" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_1861"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":1861,"slug":"parkinsons-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"extra_selectors":".auto-immune-parkinson"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_1861" class="pum-title popmake-title">
				Parkinson’s Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Parkinson’s</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Parkinson’s Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-603" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_603"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":603,"slug":"custom-protocol","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".advanced-protocols-custom-protocol"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_603" class="pum-title popmake-title">
				Custom Protocol			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font">Advanced Protocols > Custom Protocol</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">Among key components, should optimally include:<br />
TNFRSF1B – TNF RECEPTOR SUPERFAMILY MEMBER 1B<br />
PDB Code: <a href="https://www.rcsb.org/structure/3ALQ">3ALQ</a><br />
<a class="cutome-font" style="color:#6464f2;" href="https://www.rcsb.org/3d-view/3ALQ?preset=validationReport">3D Model</a><br />
<a class="cutome-font"  style="color:#6464f2;" href="https://pubchem.ncbi.nlm.nih.gov/gene/7133">Source – National Institute of Health > National Library of Medicine</a></div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Custom Protocol Guidance</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-589" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_589"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":589,"slug":"copd-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".pulmonary-copd"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_589" class="pum-title popmake-title">
				COPD Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Pulmonary > COPD (Chronic Obstructive Pulmonary Disease)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>FLT4 – FMS RELATED RECEPTOR TYROSINE KINASE 4<br />
PDB Code: <a href="https://www.rcsb.org/structure/4BSK">4BSK</a><br />
<a href="https://www.rcsb.org/3d-view/4BSK?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2324">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>COPD Protocol Guidance: 3 applications of 1 unit IV and 1 unit NEB</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-586" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_586"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":586,"slug":"proactive-regeneration-ii-high-stress-lifestyle","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".proactive-regeneration-high-stress-lifestyle"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_586" class="pum-title popmake-title">
				Proactive Regeneration II – High-Stress Lifestyle			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Proactive Regeneration > High-Stress Lifestyle</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDF11 – GROWTH DIFFERENTIATION FACTOR 11<br />
PDB Code: <a href="https://www.rcsb.org/structure/5E4G">5E4G</a><br />
<a href="https://www.rcsb.org/3d-view/5E4G?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/10220">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Proactive Regeneration II Protocol Guidance: 1 application of 2 units  IV monthly or bi-monthly</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-584" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_584"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":584,"slug":"proactive-regeneration-i-common-lifestyle","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".proactive-regeneration-common-lifestyle"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_584" class="pum-title popmake-title">
				Proactive Regeneration I – Common Lifestyle			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Proactive Regeneration > Common Lifestyle</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDF11 – GROWTH DIFFERENTIATION FACTOR 11<br />
PDB Code: <a href="https://www.rcsb.org/structure/5E4G">5E4G</a><br />
<a href="https://www.rcsb.org/3d-view/5E4G?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/10220">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Proactive Regeneration I Protocol Guidance: 1 application of 1 unit IV monthly</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-581" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_581"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":581,"slug":"wrist-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-wrist"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_581" class="pum-title popmake-title">
				Wrist Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Wrist</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Wrist Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-579" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_579"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":579,"slug":"thoracic-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-thoracic"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_579" class="pum-title popmake-title">
				Thoracic Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Thoracic</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Thoracic Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-577" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_577"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":577,"slug":"stellate-ganglion-blocks-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-stellate-ganglion-blocks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_577" class="pum-title popmake-title">
				Stellate Ganglion Blocks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Stellate Ganglion Blocks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Stellate Ganglion Blocks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA + Nerve Block</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-575" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_575"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":575,"slug":"shoulder-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-shoulder"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_575" class="pum-title popmake-title">
				Shoulder Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Shoulder</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Shoulder Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-573" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_573"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":573,"slug":"lumbar-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-lumbar"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_573" class="pum-title popmake-title">
				Lumbar Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Lumbar</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Lumbar Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-571" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_571"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":571,"slug":"knee-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-knee"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_571" class="pum-title popmake-title">
				Knee Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Knee</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Knee Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-569" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_569"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":569,"slug":"hip-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-hip"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_569" class="pum-title popmake-title">
				Hip Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Hip</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hip Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-567" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_567"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":567,"slug":"hand-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-hand"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_567" class="pum-title popmake-title">
				Hand Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Hand</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hand Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-565" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_565"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":565,"slug":"ganglion-impair-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-ganglion-impair"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_565" class="pum-title popmake-title">
				Ganglion Impair Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Ganglion Impair</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ganglion Impair Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA + Nerve Block</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-563" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_563"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":563,"slug":"foot-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-foot"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_563" class="pum-title popmake-title">
				Foot Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Foot</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Foot Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-561" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_561"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":561,"slug":"facet-joints-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-facet-joints"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_561" class="pum-title popmake-title">
				Facet Joints Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Facet Joints</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Facet Joints Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-559" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_559"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":559,"slug":"elbow-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-elbow"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_559" class="pum-title popmake-title">
				Elbow Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Elbow</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Elbow Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-556" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_556"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":556,"slug":"cervical-disks-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-cervical-disks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_556" class="pum-title popmake-title">
				Cervical Disks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Cervical Disks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Cervical Disks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-554" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_554"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":554,"slug":"ankle-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-ankle"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_554" class="pum-title popmake-title">
				Ankle Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Ankle</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ankle Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-548" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_548"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":548,"slug":"macular-degeneration-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".ophthalmology-macular-degeneration"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_548" class="pum-title popmake-title">
				Macular Degeneration Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Ophthalmology > Macular Degeneration</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>NTF3 – NEUROTROPHIN 3<br />
PDB Code: <a href="https://www.rcsb.org/structure/3BUK">3BUK</a><br />
<a href="https://www.rcsb.org/3d-view/3BUK?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/4908">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Macular Degeneration Protocol Guidance: 3 applications of 2 units IV and 1 unit IN</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-546" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_546"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":546,"slug":"thoracic-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-thoracic"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_546" class="pum-title popmake-title">
				Thoracic Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Thoracic</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Thoracic Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-544" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_544"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":544,"slug":"stroke-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-stroke"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_544" class="pum-title popmake-title">
				Stroke Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Stroke</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Stroke Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-542" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_542"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":542,"slug":"stellate-ganglion-blocks-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-stellate-ganglion-blocks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_542" class="pum-title popmake-title">
				Stellate Ganglion Blocks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Stellate Ganglion Blocks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Stellate Ganglion Blocks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA + Nerve Block</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-540" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_540"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":540,"slug":"spinal-cord-injury-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-spinal-cord-injury"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_540" class="pum-title popmake-title">
				Spinal Cord Injury Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Spinal Cord Injury</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Spinal Cord Injury Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-538" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_538"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":538,"slug":"peripheral-neuropathy-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-peripheral-neuropathy"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_538" class="pum-title popmake-title">
				Peripheral Neuropathy Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Peripheral Neuropathy</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Peripheral Neuropathy Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-536" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_536"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":536,"slug":"depression-addiction-detox-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-depression-addiction-detox"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_536" class="pum-title popmake-title">
				Depression/Addiction/Detox Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Depression/Addiction/Detox</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Depression/Addiction/Detox Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-534" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_534"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":534,"slug":"neurodegenerative-disorder-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-neurodegenerative-disorder"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_534" class="pum-title popmake-title">
				Neurodegenerative Disorder Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Neurodegenerative Disorder</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Neurodegenerative Disorder Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-532" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_532"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":532,"slug":"lumbar-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-lumbar"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_532" class="pum-title popmake-title">
				Lumbar Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font">Specialties > Neurological > Lumbar</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Lumbar Protocol Guidance: 3 applications of 4cc IV and 4cc IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-529" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_529"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":529,"slug":"ganglion-impair-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-ganglion-impair"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_529" class="pum-title popmake-title">
				Ganglion Impair Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font">Specialties > Neurological > Ganglion Impair</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ganglion Impair Protocol Guidance: 3 applications of 4cc IV and 4cc IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-527" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_527"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":527,"slug":"facet-joints-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-facet-joints"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_527" class="pum-title popmake-title">
				Facet Joints Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Facet Joints</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Facet Joints Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-524" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_524"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":524,"slug":"cervical-discs-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-cervical-discs"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_524" class="pum-title popmake-title">
				Cervical Discs Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Cervical Discs</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Cervical Discs Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-521" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_521"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":521,"slug":"wounds-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-wounds"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_521" class="pum-title popmake-title">
				Wounds Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Wounds</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Wounds Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-519" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_519"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":519,"slug":"ulcers-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-ulcers"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_519" class="pum-title popmake-title">
				Ulcers Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Ulcers</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ulcers Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-517" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_517"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":517,"slug":"neck-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-neck"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_517" class="pum-title popmake-title">
				Neck Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Neck</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Neck Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-515" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_515"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":515,"slug":"leg-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-leg"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_515" class="pum-title popmake-title">
				Leg Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Leg</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Leg Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-513" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_513"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":513,"slug":"skin-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-skin"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_513" class="pum-title popmake-title">
				Skin Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Skin</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Skin Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-511" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_511"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":511,"slug":"hair-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-hair"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_511" class="pum-title popmake-title">
				Hair Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Hair</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hair Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-509" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_509"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":509,"slug":"face-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-face"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_509" class="pum-title popmake-title">
				Face Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Face</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Face Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-506" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_506"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":506,"slug":"burns-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-burns"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_506" class="pum-title popmake-title">
				Burns Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Burns</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Burns Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-503" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_503"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":503,"slug":"anti-aging-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-anti-aging"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_503" class="pum-title popmake-title">
				Anti-Aging Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Anti-Aging</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDF11 – GROWTH DIFFERENTIATION FACTOR 11<br />
PDB Code: <a href="https://www.rcsb.org/structure/5E4G">5E4G</a><br />
<a href="https://www.rcsb.org/3d-view/5E4G?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/10220">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Anti-Aging Protocol Guidance: 1 application of 2 units IV not less often than monthly<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-500" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_500"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":500,"slug":"arm-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-arm"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_500" class="pum-title popmake-title">
				Arm Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Arm</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Arm Protocol Guidance: 1 application of 2 units IV not less often than monthly<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-497" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_497"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":497,"slug":"wrist-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-wrist"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_497" class="pum-title popmake-title">
				Wrist Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Wrist</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Wrist Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-495" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_495"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":495,"slug":"thoracic-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-thoracic"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_495" class="pum-title popmake-title">
				Thoracic Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Thoracic</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Thoracic Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-493" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_493"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":493,"slug":"stellate-ganglion-blocks-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-stellate-ganglion-blocks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_493" class="pum-title popmake-title">
				Stellate Ganglion Blocks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Stellate Ganglion Blocks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Stellate Ganglion Blocks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-491" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_491"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":491,"slug":"shoulder-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-shoulder"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_491" class="pum-title popmake-title">
				Shoulder Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Shoulder</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Shoulder Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-489" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_489"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":489,"slug":"lumbar-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-lumbar"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_489" class="pum-title popmake-title">
				Lumbar Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Lumbar</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Lumbar Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-487" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_487"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":487,"slug":"knee-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-knee"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_487" class="pum-title popmake-title">
				Knee Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Knee</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Knee Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-485" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_485"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":485,"slug":"hip-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-hip"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_485" class="pum-title popmake-title">
				Hip Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Hip</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hip Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-483" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_483"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":483,"slug":"hand-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-hand"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_483" class="pum-title popmake-title">
				Hand Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Hand</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hand Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-481" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_481"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":481,"slug":"ganglion-impair-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-ganglion-impair"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_481" class="pum-title popmake-title">
				Ganglion Impair Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Ganglion Impair</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ganglion Impair Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-479" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_479"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":479,"slug":"foot-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-foot"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_479" class="pum-title popmake-title">
				Foot Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Foot</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Foot Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-477" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_477"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":477,"slug":"facet-joints-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-facet-joints"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_477" class="pum-title popmake-title">
				Facet Joints Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Facet Joints</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Facet Joints Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-474" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_474"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":474,"slug":"elbow-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-elbow"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_474" class="pum-title popmake-title">
				Elbow Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Elbow</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Elbow Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-470" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_470"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":470,"slug":"cervical-disks-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-cervical-disks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_470" class="pum-title popmake-title">
				Cervical Disks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Cervical Disks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Cervical Disks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-467" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_467"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":467,"slug":"ankle-protocol-guidance-chiropractic","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-ankle"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_467" class="pum-title popmake-title">
				Ankle Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Ankle</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ankle Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-463" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_463"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":463,"slug":"vasculature-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cardiological-vasculature"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_463" class="pum-title popmake-title">
				Vasculature Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cardiological</a> > Vasculature</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>VEGFA – VASCULAR ENDOTHELIAL GROWTH FACTOR A<br />
PDB Code: <a href="https://www.rcsb.org/structure/6ZFL">6ZFL</a><br />
<a href="https://www.rcsb.org/3d-view/6ZFL?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/7422">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Vasculature Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-459" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_459"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":459,"slug":"myocardial-infarction-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cardiological-myocardialinfarction"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_459" class="pum-title popmake-title">
				Myocardial Infarction Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cardiological</a> > Myocardial Infarction</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>VEGFA – VASCULAR ENDOTHELIAL GROWTH FACTOR A<br />
PDB Code: <a href="https://www.rcsb.org/structure/6ZFL">6ZFL</a><br />
<a href="https://www.rcsb.org/3d-view/6ZFL?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/7422">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Myocardial Infarction Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-455" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_455"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":455,"slug":"peripheral-arterial-disease-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cardiological-peripheralarterialdisease"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_455" class="pum-title popmake-title">
				Peripheral Arterial Disease Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cardiological</a> > Peripheral Arterial Disease</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>VEGFA – VASCULAR ENDOTHELIAL GROWTH FACTOR A<br />
PDB Code: <a href="https://www.rcsb.org/structure/6ZFL">6ZFL</a><br />
<a href="https://www.rcsb.org/3d-view/6ZFL?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/7422">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Peripheral Arterial Disease Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li style="list-style-type: none;">
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
</ul>
<p></ul class=”cutome-font”></li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong>Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-443" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_443"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":443,"slug":"peripheral-neuropathy-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cardiological-peripheralneuropathy"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_443" class="pum-title popmake-title">
				Peripheral Neuropathy Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Cardiological > Peripheral Neuropathy</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>VEGFA – VASCULAR ENDOTHELIAL GROWTH FACTOR A<br />
PDB Code: <a href="https://www.rcsb.org/structure/6ZFL">6ZFL</a><br />
<a href="https://www.rcsb.org/3d-view/6ZFL?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/7422">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Peripheral Neuropathy Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-439" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_439"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":439,"slug":"thyroid-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-thyroidprotocol"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_439" class="pum-title popmake-title">
				Thyroid Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Thyroid</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Thyroid Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-432" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_432"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":432,"slug":"rheumatoid-arthritis-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-rheumatoidarthritis"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_432" class="pum-title popmake-title">
				Rheumatoid Arthritis Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Rheumatoid Arthritis (RA)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code:<a href="https://www.rcsb.org/structure/1ALU"> 1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Rheumatoid Arthritis Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-428" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_428"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":428,"slug":"multiple-sclerosis-ms-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-multiplesclerosis"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_428" class="pum-title popmake-title">
				Multiple Sclerosis (MS) Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Multiple Sclerosis (MS)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Multiple Sclerosis Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-423" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_423"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":423,"slug":"irritable-bowel-syndrome-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-irritablebowel"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_423" class="pum-title popmake-title">
				Irritable Bowel Syndrome Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Irritable Bowel Syndrome (IBS) </strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Irritable Bowel Syndrome Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-420" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_420"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":420,"slug":"hashimotos-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-hashimotos"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_420" class="pum-title popmake-title">
				Hashimoto’s Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Hashimoto’s</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hashimoto’s Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-417" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_417"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":417,"slug":"fibromyalgia-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-fibromyalgia"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_417" class="pum-title popmake-title">
				Fibromyalgia Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Fibromyalgia</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Fibromyalgia Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-412" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_412"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":412,"slug":"diabetes-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-diabetes"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_412" class="pum-title popmake-title">
				Diabetes Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-immune</a> > Diabetes</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Diabetes Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-407" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_407"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":407,"slug":"crohns-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-crohns"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_407" class="pum-title popmake-title">
				Crohn’s Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Crohn’s</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Crohn’s Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-397" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_397"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":397,"slug":"autism-non-acute","theme_id":326,"cookies":[],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-autism-non"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_397" class="pum-title popmake-title">
				Autism (Non-Acute) Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Autism (Non-Acute)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<p><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></p>
</div>
<div class="popupdetailheader"><strong>Autism (Non-Acute) Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-335" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_335"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":335,"slug":"autism-acute","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-autism"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_335" class="pum-title popmake-title">
				Ankle Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font">Specialties > Auto-Immune > Autism (Acute)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol">
<p><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></p>
</div>
</div>
<div class="popupdetailheader"><strong>Autism (Acute) Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>*Lumbar puncture for severe older patients</li>
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>